BACKGROUND: The only cure for primary hyperparathyroidism (1 degrees HPT) is parathyroidectomy. However, many elderly patients are not referred for surgery due to medical comorbidities and/or advanced age. The purpose of this study was to evaluate benefits against risks of parathyroidectomy in this patient population. MATERIALS AND METHODS: From March 2001 to June 2006, 50 patients aged 80 years or older with 1 degrees HPT underwent parathyroidectomy by a single surgeon. Clinical presentation and surgical outcomes of all patients were evaluated. The standard form of the SF-36 Health Survey, designed to measure patient quality of life (QOL), was completed by a subset of patients. RESULTS: There were 45 females and 5 males with a mean age of 83 +/- 2 y. Patient comorbidities included hypertension (72%), coronary artery disease (22%), diabetes mellitus (16%), chronic obstructive pulmonary disease (10%), and congestive heart failure (10%). Bone pain was the most common primary presenting symptom (44%), followed by fatigue (12%), confusion (6%), and joint pain (6%). Eleven patients (22%) had ectopic glands. The cure rate postsurgery was 98% (49/50). There were 2 postoperative complications (4%): one patient with transient hypocalcemia and another with cellulitus at an i.v. site. Of patients who completed QOL surveys, greater than 60% reported improved physical functioning, social functioning, and/or mental health, and reduction of bodily pain. CONCLUSION: Parathyroidectomy is safe and curative for octogenarians and nonagenarians with 1 degrees HPT, and maintains or improves quality of life. The surgical benefits outweigh operative risks, making parathyroid surgery an excellent option for patients over 80 years of age.
BACKGROUND: The only cure for primary hyperparathyroidism (1 degrees HPT) is parathyroidectomy. However, many elderly patients are not referred for surgery due to medical comorbidities and/or advanced age. The purpose of this study was to evaluate benefits against risks of parathyroidectomy in this patient population. MATERIALS AND METHODS: From March 2001 to June 2006, 50 patients aged 80 years or older with 1 degrees HPT underwent parathyroidectomy by a single surgeon. Clinical presentation and surgical outcomes of all patients were evaluated. The standard form of the SF-36 Health Survey, designed to measure patient quality of life (QOL), was completed by a subset of patients. RESULTS: There were 45 females and 5 males with a mean age of 83 +/- 2 y. Patient comorbidities included hypertension (72%), coronary artery disease (22%), diabetes mellitus (16%), chronic obstructive pulmonary disease (10%), and congestive heart failure (10%). Bone pain was the most common primary presenting symptom (44%), followed by fatigue (12%), confusion (6%), and joint pain (6%). Eleven patients (22%) had ectopic glands. The cure rate postsurgery was 98% (49/50). There were 2 postoperative complications (4%): one patient with transient hypocalcemia and another with cellulitus at an i.v. site. Of patients who completed QOL surveys, greater than 60% reported improved physical functioning, social functioning, and/or mental health, and reduction of bodily pain. CONCLUSION: Parathyroidectomy is safe and curative for octogenarians and nonagenarians with 1 degrees HPT, and maintains or improves quality of life. The surgical benefits outweigh operative risks, making parathyroid surgery an excellent option for patients over 80 years of age.
Authors: Bian Wu; Philip I Haigh; Roy Hwang; Philip H G Ituarte; In-Lu Amy Liu; Theodore J Hahn; Michael W Yeh Journal: J Clin Endocrinol Metab Date: 2010-07-07 Impact factor: 5.958
Authors: Irene Lou; Courtney Balentine; Samuel Clarkson; David F Schneider; Rebecca S Sippel; Herbert Chen Journal: Surgery Date: 2016-11-15 Impact factor: 3.982
Authors: Sara E Murray; Priya R Pathak; David S Pontes; David F Schneider; Sarah C Schaefer; Herbert Chen; Rebecca S Sippel Journal: Surgery Date: 2013-10-04 Impact factor: 3.982
Authors: Milan D Jovanovic; Vladan R Zivaljevic; Aleksandar D Diklic; Branislav R Rovcanin; Goran V Zoric; Ivan R Paunovic Journal: Eur Arch Otorhinolaryngol Date: 2016-09-12 Impact factor: 2.503